Latest Regulatory News

Page 11 of 874
VRX Silica has kicked off a $6.23 million renounceable entitlement offer, underwritten to $2 million, to fund key development activities at its Arrowsmith North silica sand project including a strategic property purchase and engineering works.
Maxwell Dee
Maxwell Dee
28 May 2026
Actinogen Medical has obtained positive scientific advice from the European Medicines Agency that aligns with prior FDA guidance, clarifying regulatory requirements for its Alzheimer’s drug Xanamem and paving the way for a streamlined approval process in major markets.
Ada Torres
Ada Torres
28 May 2026
Terragen Holdings secures a landmark supply agreement for its probiotic and biostimulant products with Ravensworth Feedlot, alongside a $2.8 million funded trial at Mort & Co’s Grassdale feedlot to validate its probiotic’s impact on cattle performance.
Ada Torres
Ada Torres
28 May 2026
Viking Mines reports a major metallurgical breakthrough at its Linka Tungsten Project, achieving a 62.5% WO3 concentrate at 59.8% recovery using combined gravity and flotation processing on a larger 10 kg sample, significantly improving previous results and validating a low-capex flowsheet ahead of maiden drilling.
Maxwell Dee
Maxwell Dee
28 May 2026
Nexalis Therapeutics has locked in a $53 million non-dilutive funding facility with Point8 Capital, replacing its previous lender and supporting three clinical programs targeting breakthrough cancer pain, panic disorder, and treatment-resistant depression.
Ada Torres
Ada Torres
28 May 2026
The Therapeutic Goods Administration has broadened the range of clinicians eligible to participate in psychedelic-assisted psychotherapy, a move set to speed up recruitment and improve patient access across Emyria’s national Empax network.
Ada Torres
Ada Torres
28 May 2026
Li-FT Power Ltd. has released an extensive update to its Corporate Governance Statement, outlining its board structure, committee roles, and compliance with Canadian and ASX governance standards. The company highlights partial adherence to some ASX recommendations, reflecting its current development stage.
Maxwell Dee
Maxwell Dee
28 May 2026
Imugene has dosed the first patient in a new cohort combining its azer-cel CAR T therapy with BTK inhibitors, targeting patients with B-cell malignancies who failed prior BTKi treatment. This move broadens the trial’s scope and tackles a significant unmet need in blood cancer therapy.
Ada Torres
Ada Torres
28 May 2026
Develop Global’s Pioneer Dome lithium project hits high-grade infill drilling results surpassing resource expectations, setting the stage for a Final Investment Decision next month on an 850,000-tonne DSO operation.
Maxwell Dee
Maxwell Dee
28 May 2026
Beonic Ltd (ASX:BEO) has initiated a $3 million pro-rata renounceable entitlement offer at $0.08 per share, partially underwritten by Alpine Capital, to shore up working capital and repay shareholder loans. The offer carries potential dilution of 35.7% for non-participating shareholders and may increase the Thorney Group's voting power significantly.
Sophie Babbage
Sophie Babbage
28 May 2026
Brightstar Resources has intersected visible gold in multiple deep diamond drillholes at Two Mile Hill, part of its Sandstone Gold Project. The drilling extends beyond 550m depth, underpinning plans for an underground mining study in the pre-feasibility study due later this year.
Maxwell Dee
Maxwell Dee
28 May 2026
EV Resources has cleared a critical regulatory hurdle by obtaining the Change of Use of Soil permit for its Tecomatlán Plant, enabling the final environmental report filing and grid connection application that pave the way for near-term antimony production.
Maxwell Dee
Maxwell Dee
28 May 2026